NuCana plc (NCNA)
NASDAQ
$1.32+$0.0100 (+0.76%) on the dayAs of the close; data may be delayed.
NCNA price, last 12 months
Key stats
- Previous close
- $1.31
- Open
- $1.31
- Day range
- $1.27 – $1.34
- 52-week range
- $1.21 – $7.22
- Volume
- 9.3K
- Avg volume (20 days)
- 89.9K
- Market cap
- $5.3M
Performance
1W−0.8%
1M−10.2%
3M−17.5%
6M−13.7%
YTD−63.3%
1Y−66.1%
vs S&P 500, 1Y−82.9 pts
Technicals and fundamentals
About NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
- Listed on
- NASDAQ
- Market cap
- $5.3M